Production (Stage)
D
Verrica Pharmaceuticals Inc. VRCA
$0.6117 -$0.0083-1.34% NASDAQ
Recommendation
Prev Close
$0.6117
Volume
112,041
Avg Vol (90D)
354,341
Market Cap
$56.58M
Dividend & Yield
--
52-Week Range
$0.3816 - $9.36
P/E (TTM)
--
EPS (TTM)
-$1.20
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Wall Street Zen Upgrades Verrica Pharmaceuticals (NASDAQ:VRCA) to "Hold"
5/24/2025 - MarketBeat
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Given Average Recommendation of "Hold" by Analysts
5/24/2025 - MarketBeat
Verrica Pharmaceuticals (NASDAQ:VRCA) Stock Rating Upgraded by Wall Street Zen
5/24/2025 - Ticker Report
Research Analysts Offer Predictions for VRCA Q2 Earnings
5/20/2025 - MarketBeat
Verrica Pharmaceuticals (VRCA) Receives Hold Rating from Needham VRCA Stock News
5/14/2025 - GuruFocus
Verrica Pharmaceuticals Inc (VRCA) Q1 2025 Earnings Call Highlights: Strong YCANTH Demand and ...
5/14/2025 - GuruFocus
Q1 2025 Verrica Pharmaceuticals Inc Earnings Call Transcript
5/14/2025 - GuruFocus
Verrica Pharmaceuticals Reports Strong Q1 2025 Growth
5/14/2025 - TipRanks Financial Blog
Verrica Pharmaceuticals (VRCA) Sees Q1 Revenue Growth Driven by YCANTH
5/13/2025 - GuruFocus
Verrica Pharmaceuticals, Inc. (VRCA) Q1 2025 Corporate Update Conference Call
5/13/2025 - Seeking Alpha: Transcripts
Verrica Pharmaceuticals, Inc. (VRCA) Q1 2025 Corporate Update Conference Call
5/13/2025 - SeekingAlpha
Verrica Pharmaceuticals Inc. (VRCA) Reports Q1 Loss, Tops Revenue Estimates
5/13/2025 - Zacks Investment Research
Verrica Pharmaceuticals (VRCA) Reports Strong Q1 Revenue and Advances Clinical Pipeline VRCA ...
5/13/2025 - GuruFocus
Verrica Pharmaceuticals Q1 2025 Earnings: EPS Misses, Revenue Surpasses Estimates with $3.4 Million
5/13/2025 - GuruFocus
Verrica Pharmaceuticals Reports Quarterly 2025 Financial Results
5/13/2025 - GuruFocus
Verrica Pharmaceuticals reports Q1 EPS (10c), consensus (14c)
5/13/2025 - The Fly
Verrica Pharmaceuticals Reports Quarterly 2025 Financial Results
5/13/2025 - Globe Newswire
Assertio (ASRT) Reports Q1 Loss, Misses Revenue Estimates
5/12/2025 - Zacks Investment Research
Earnings To Watch: Verrica Pharmaceuticals Inc (VRCA) Reports Q1 2025 Result
5/12/2025 - GuruFocus
4D Molecular Therapeutics, Inc. (FDMT) Reports Q1 Loss, Lags Revenue Estimates
5/8/2025 - Zacks Investment Research
Verrica Pharmaceuticals to Report First Quarter 2025 Financial Results and Provide a Corporate ...
5/7/2025 - GuruFocus
Verrica Pharmaceuticals to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 13, 2025
5/7/2025 - Globe Newswire
Amneal Pharmaceuticals (AMRX) Q1 Earnings Beat Estimates
5/2/2025 - Zacks Investment Research
Verrica Pharmaceuticals to Participate in the Citizens Life Sciences Conference in New York
4/30/2025 - GuruFocus
Verrica Pharmaceuticals to Participate in the Citizens Life Sciences Conference in New York
4/30/2025 - Globe Newswire
Income Statement
Total Revenue (TTM)
$7.18M
EBITDA (TTM)
-$54.53M
EBIT (TTM)
-$55.37M
Net Income (TTM)
-$65.99M
Balance Sheet
Total Assets (Q)
$42.18M
Total Debt (Q)
$42.43M
Total Liabilities (Q)
$60.75M
Book Value Per Share (Q)
-$0.2024
Cash Flow
Cash from Operations (TTM)
-$53.66M
Cash from Investing (TTM)
-$19.00K
Cash from Financing (TTM)
$34.33M
Net Change in Cash (TTM)
-$19.34M
Filings
Filing Date
Tuesday, May 13, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Aug 11 and 15 (est)
Price History
Loading...
Beta
1.85
7-Day Total Return
-4.69%
30-Day Total Return
26.38%
60-Day Total Return
-5.76%
90-Day Total Return
-7.79%
Year to Date Total Return
-12.94%
1-Year Total Return
-92.85%
2-Year Total Return
-89.81%
3-Year Total Return
-89.00%
5-Year Total Return
-94.92%
52-week Low
Apr 03, 2025 - $0.3816
52-week High
Jun 06, 2024 - $9.36
Valuation
Market Cap
$56.58M - Micro Cap
Enterprise Value
$69.41M
Price/Sales (TTM)
8.09
Price/Book (Q)
-3.02
Dividends and Shares
Shares Outstanding
94.84M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.verrica.com
Phone Number
484 453 3300
Address
44 West Gay Street
West Chester, PA 19380
Country
United States
Year Founded
2013
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and sale of medications for the treatment of skin diseases in the United States. The company’s product... more
NASDAQ 05/23/2025 4:00PM Eastern Quotes delayed